Routine biomarkers for HF diagnosis, especially natriuretic peptides such as N-terminal pro-brain natriuretic peptide (NT-proBNP), are useful but show some limitations for HF prognostication post-MI due to fluctuations of their circulating levels during the first few days after MI [4]. This evidence concerns the gene NPPB and hydrops fetalis.